Tomotherapy

radiotherapy tolerance tests

SHORT VERSION

Tomotherapy allows the precise tumor targeting by radiation

Tomotherapy allows the precise tumor targeting by radiation through the daily repositioning of the patient before irradiation using CT imaging. In this radiotherapy technique, the radiation beam intensity is continuously modified during the irradiation to better protect the healthy tissues (i.e. intensity-modulation radiation therapy). The table on which the patient is positioned at the beginning of the session moves continuously during irradiation while the beam rotates around the patient, making a spiral. This is called helical tomotherapy.

This technique is generally indicated for patients with complex tumors located near sensitive organs (particularly ENT tumors near the salivary glands) to whom irradiation may cause important side effects. It also allows the treatment of large tumor volumes, particularly childhood cancers, such as medulloblastoma where the treatment will target the entire spinal cord, or large sarcomas. Each tomotherapy session lasts approximately 30 minutes.

Radiotherapy hair loss

Notez cet post

FIRST TESTS TO PREDICT A PATIENT’S RADIOSENSITIVITY

NovaGray develops and commercializes the first radiotherapy tolerance tests for patients treated for breast or prostate cancer.

Performed before the start of radiotherapy with a simple blood draw, the tests assess the patients’ individual radiosensitivity and determine their risk of developing late complications after radiotherapy.

WHY DO A RADIOSENSITIVITY TEST?

Knowing a patient’s individual radiosensitivity is important information that can help:

  • Reassure the patient in preparation for radiotherapy
  • Guide physicians in choosing the most appropriate treatment plan
  • Adapt patient follow-up after radiotherapy

Team NovaGray

NovaGray develops radiotherapy tolerance tests for breast and prostate cancer patients. NovaGray's mission is to help personalize cancer treatment by assessing each patient's individual sensitivity before starting radiotherapy. NovaGray technology has been validated by multi-center prospective clinical trials. NovaGray tests are recommended by the French Society of Radiation Oncology (SFRO).